More than five drug candidates from his team progressed to human trials including drugs like Rilematovir (Phase IIb), and Bedaquiline
The agreement pairs Croda’s global footprint and “smart science” approach with Amino’s precision manufacturing capabilities
Biocon will acquire the residual stake held by Mylan (Viatris) for a total consideration of US$ 815 million
Here's a development that aims to keep your blood pressure in check. Literally!
PLI scheme for Bulk Drugs has a total budgetary outlay of Rs. 6,940 crore
The partnership combines Croda’s deep expertise in smart science and global market reach with Amino’s advanced capabilities in precision manufacturing of amino acids
Under the agreement, Evonik will distribute InVitria’s blood-free rHSA portfolio to its biopharma customers
Patients on baxdrostat showed a significant reduction in systolic blood pressure (SBP) compared to placebo
Conventional plasmids as a pharmaceutical material are not only suboptimal in safety and function, but exceedingly costly to produce, prohibitively
Tezspire nearly eliminated the need for surgery, reducing surgical intervention by 98 per cent
Subscribe To Our Newsletter & Stay Updated
